Clinical trials. A pending subject

被引:2
|
作者
Gil-Extremera, B. [1 ]
Jimenez-Lopez, P. [1 ]
Mediavilla-Garcia, J. D. [1 ]
机构
[1] Univ Granada, Dept Med, Granada, Spain
来源
REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 03期
关键词
Clinical trial; Hypertension; Diabetes; Dyslipidaemia; HIGH-RISK PATIENTS; SYSTOLIC HYPERTENSION; EFFICACY; EVENTS; SAFETY; TELMISARTAN; PREVENTION; DEMENTIA; OUTCOMES; OLDER;
D O I
10.1016/j.rce.2017.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical trials are essential tools for the progress of clinical medicine in its diagnostic and therapeutic aspects. Since the first trial in 1948, which related tobacco use with lung cancer, there have been more than 150,000 clinical trials to date in various areas (paediatrics, cardiology, oncology, endocrinology, etc.). This article highlights the importance for all physicians to participate, over the course of their professional career, in a clinical trial, due to the inherent benefits for patients, the progress of medicine and for curricular prestige. The authors have created a synthesis of their experience with clinical trials on hypertension, diabetes, dyslipidaemia and ischaemic heart disease over the course of almost 3 decades. Furthermore, a brief reference has been made to the characteristics of a phase I unit, as well as to a number of research studies currently underway. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 50 条
  • [31] Enrollment of women in cardiovascular clinical trials. Reply
    Douglas, PS
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26): : 1973 - 1973
  • [32] Poverty and survival in targeted immunotherapy clinical trials.
    Bona, Kira O'Neil
    Li, Yimei
    Winestone, Lena
    Getz, Kelly D.
    Huang, Yuan-Shung
    Fisher, Brian
    Desai, Ami Vijay
    Richardson, Troy
    Hall, Matt
    Naranjo, Arlene
    Henderson, Tara O.
    Aplenc, Richard
    Bagatell, Rochelle
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Pharmaceutical involvement in breast cancer clinical trials.
    Peppercorn, JM
    Blood, E
    Winer, EP
    Partridge, AH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 542S - 542S
  • [34] Quality of life and participation in osteoporosis clinical trials.
    Kessenich, CR
    Rosen, CJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : T572 - T572
  • [35] Outcome measures in psoriatic arthritis clinical trials.
    Reddy S.M.
    Bingham Iii C.O.
    Current Rheumatology Reports, 2005, 7 (4) : 299 - 305
  • [36] Diet and coronary heart disease: clinical trials.
    Brousseau M.E.
    Schaefer E.J.
    Current Atherosclerosis Reports, 2000, 2 (6) : 487 - 493
  • [37] Premature termination of genitourinary cancer clinical trials.
    Stensland, Kristian D.
    McBride, Russell
    Wisnivesky, Juan P.
    Latif, Asma
    Hendricks, Ryan
    Roper, Nitin
    Boffetta, Paolo
    Hall, Simon J.
    Oh, William K.
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [38] Recruitment and retention of subjects for clinical leiomyoma trials.
    McCarthy-Keith, D.
    Blocker, W.
    Levens, E.
    Nieman, L.
    Armstrong, A.
    FERTILITY AND STERILITY, 2007, 88 : S219 - S219
  • [39] The pre-requisites for acne clinical trials.
    OBrien, SC
    Hick, P
    Cunliffe, WJ
    Holland, KT
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (03) : 116 - 116
  • [40] Barriers exist to patient participation in clinical trials.
    Guarino, MJ
    Masters, GA
    Schneider, CJ
    Biggs, DD
    Grubbs, SS
    Himelstein, AL
    Martin, SE
    Michaels, LM
    Guarino, AJ
    Rejtos, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 531S - 531S